SanaClis heading for five conferences in USA and Europe

news-releasesSanaClis s.r.o.
May 7th 2018

Bratislava, Slovakia: – Award-winning full service CRO SanaClis is planning to attend five leading clinical trials-oriented events on two continents during May 2018.

Beginning with the three days Evolution Spring Summit in Miami on May 7-9, SanaClis will attend further networking conferences on the US West Coast the following week.

These are the Proventa International-organized Oncology Strategy Meeting USA and Clinical Operations Strategy Meeting USA, both being staged at The Hyatt Regency Airport in San Francisco, California over two successive days, May 14 and 15.

The Oncology Strategy Meeting will provide SanaClis with the opportunity to take part in discussions focusing on the latest oncology trends and to share knowledge and insights with fellow industry professionals.

“We are looking forward to discuss the emerging topics in the field of oncology, such as biomarkers, cancer genomics and immuno-oncology” commented SanaClis Managing Partner Alexander Fetkovsky.

Alexander Fetkovsky, who is a member of the SanaClis Board, has an extensive career in the CRO and cold chain management industry, with overall responsibility for the planning and execution of strategic initiatives and business partnering, as well as operational and financial oversight for multiple clinical programs and clinical trial supply/warehouse operations.

Two-days Russian Pharmaceutical Forum, organized by Adam Smith Conferences, will take place at the Corinthia Saint-Petersburg Hotel in St. Petersburg, Russia on May 15-16.

“Attending Operations Strategy Meeting USA and Russian Pharmaceutical Forum in parallel gives us a great opportunity to meet with industry professionals, international and local pharmaceutical producers, distributors and retailers from both continents” said Mr. Fetkovsky.

“It is also a chance to develop new business opportunities, leveraging on our experience and strong logistics network across Central and Eastern Europe”, he added.

On May 23, Mr. Fetkovsky will be present in Munich for the opening of the one-day Clinical Operations Strategy Meeting Europe, also organized by Proventa International.

As with its sister event in San Francisco, SanaClis plans to use the meeting to promote its services, share insights, network with industry professionals and primary decision makers of established and emerging pharma, biotech and biopharma companies.

“It is always a pleasure and a good experience to meet industry professionals and exchange the point of view on the key topics like clinical operations, patient recruitment, clinical outsourcing, risk-based monitoring and eTMF”, said Mr. Fetkovsky.

About SanaClis

SanaClis is a full-service European CRO offering a comprehensive range of services for clinical trials.

SanaClis has experience of successfully delivering studies for various sized sponsors, starting from virtual biotechs through to top 10 pharma companies. Every project is a priority for the SanaClis team, irrespective size or scope. The company’s operations are guided by firm belief, that every company and professional partner deserves the best possible service, responsiveness and dedication, which SanaClis routinely provides to all clients.

In additional to being a full service CRO, SanaClis is one of the very few service providers with in-house logistics capabilities. These include QP services, IMP/CT management, customs brokerage, warehousing and distribution and sourcing of clinical trial materials, comparators and rescue medication.